If you felt a sense of trepidation after reading the results of the new LEAP-On follow-up study, you’re not alone – many people in the food allergy community are going through a bout of culture shock. There’s no denying that the results of 2015’s LEAP and this month’s LEAP-On are quite phenomenal – a 74… Read more »
We bring you extensive coverage from the largest gathering of allergists in the world.
A pharmaceutical approach to oral immunotherapy is a step closer to approval by the Food and Drug Administration. The treatment, called AR101, is being developed by a company called Aimmune Therapeutics. The company’s aim is to make people less allergic to peanuts by having them take a specially formulated peanut powder in increasing doses over… Read more »
While oral immunotherapy for peanut allergy grabs plenty of headlines, the question is often raised whether the technique will work for tree nuts as well. In a study presented at the AAAAI meeting in March 2016, researchers from the University of Arkansas say they’ve observed that walnut OIT can effectively and safely desensitize patients to… Read more »
Exposure comes from touching surfaces and then accidentally ingesting peanut, researchers say.
Expanded survey looked at more than 6,500 elementary, middle and high schools.
Highly positive results seen for early peanut and egg introduction, but more study needed on other allergens.
Case will now see two sides exchange evidence and attend mandatory mediation.
In a long-term follow-up study, oral immunotherapy (OIT) patients who were treated for up to five food allergies were able to maintain a high level of desensitization to their allergens, even those taking very low “doses” of their allergens.
Many patients with eczema go on to develop food allergies, a phenomenon often referred to as “the allergic march.”